SCHEMBL30262091

CC(C)C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O)[C@@H](C)O

nearest known ligand 0.58

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	VIPR2	P41587	7/20	0.58

▸	VIPR1	P32241	5/20	0.58

▸	GLP1R	P43220	9/20	0.55

▸	SCTR	P47872	1/20	0.55

▸	TFPI	P10646	1/20	0.53

▸	GCGR	P47871	1/20	0.52

▸	KISS1R	Q969F8	2/20	0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30910839	0.90	VIPR1 (0.65)	VIPR2VIPR1GLP1RSCTRTFPI
SCHEMBL29939717	0.90	VIPR1 (0.66)	VIPR2VIPR1GLP1RSCTRGCGR
SCHEMBL30607419	0.89	GLP1R (0.65)	VIPR2VIPR1GLP1RSCTRTFPI
SCHEMBL31182665	0.89	VIPR1 (0.68)	VIPR2VIPR1GLP1R
SCHEMBL30512618	0.88	GLP1R (0.56)	VIPR2VIPR1GLP1RSCTRGCGR
SCHEMBL30974556	0.88	GLP1R (0.54)	VIPR2VIPR1GLP1RSCTRTFPI
SCHEMBL29854442	0.88	VIPR2 (0.67)	VIPR2VIPR1GLP1R
SCHEMBL30277571	0.88	TFPI (0.58)	VIPR2GLP1RSCTRTFPIGCGR
SCHEMBL29526513	0.87	GLP1R (0.57)	VIPR2VIPR1GLP1RSCTRTFPI
SCHEMBL31182489	0.87	GLP1R (0.66)	VIPR2VIPR1GLP1RSCTRTFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20230040544-A1	COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC)	SAREPTA THERAPEUTICS, INC.	2023-02-09	—	—	US	disclosed